Trupanion (NASDAQ:TRUP) Trading Up 8.2% – Time to Buy?

Trupanion, Inc. (NASDAQ:TRUP)’s share price shot up 8.2% during mid-day trading on Wednesday . The stock traded as high as $47.35 and last traded at $47.25. 341,783 shares were traded during mid-day trading, a decline of 45% from the average session volume of 622,976 shares. The stock had previously closed at $43.65.

Analysts Set New Price Targets

TRUP has been the topic of several analyst reports. Bank of America upped their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Piper Sandler upped their price objective on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Stifel Nicolaus lifted their target price on Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Finally, Northland Securities upped their price target on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Trupanion currently has an average rating of “Moderate Buy” and a consensus price target of $45.33.

Trupanion Stock Performance

The business has a 50-day moving average of $51.08 and a 200 day moving average of $45.31. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The company has a market cap of $2.02 billion, a PE ratio of -148.84, a PEG ratio of 7.79 and a beta of 1.61.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The firm had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same quarter in the prior year, the firm earned ($0.10) EPS. The business’s revenue for the quarter was up 14.6% compared to the same quarter last year. Equities research analysts anticipate that Trupanion, Inc. will post -0.2 EPS for the current fiscal year.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 622 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the sale, the chief financial officer now directly owns 9,867 shares of the company’s stock, valued at approximately $519,102.87. This represents a 5.93 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Murray B. Low sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total transaction of $105,340.00. Following the sale, the director now owns 131,513 shares in the company, valued at approximately $6,926,789.71. The trade was a 1.50 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,597 shares of company stock worth $1,522,082 in the last 90 days. 5.50% of the stock is currently owned by insiders.

Institutional Trading of Trupanion

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Bartlett & CO. Wealth Management LLC purchased a new position in shares of Trupanion during the 4th quarter valued at $266,000. Ameritas Advisory Services LLC purchased a new position in shares of Trupanion in the fourth quarter valued at about $389,000. GAMMA Investing LLC boosted its stake in shares of Trupanion by 18.5% in the fourth quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock worth $82,000 after acquiring an additional 267 shares during the period. JPMorgan Chase & Co. grew its position in shares of Trupanion by 2.7% during the third quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock worth $1,189,000 after purchasing an additional 738 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of Trupanion during the third quarter worth about $54,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.